March, 2018-Present:• Primary/Lead CRA on Hepatitis C device trial• Perform site monitoring nationwide at all participating study sites• Work directly with Sponsor management team to review and approve subject eligibility, re-develop database and CCGs, institute recruitment initiatives and create study management tools• EDC: ClinSparkJuly, 2017-Present:• All aspects of monitoring for Phase 2 Metastatic Breast Cancer Study• Responsible for regulatory reconciliation of central oncology network • Prepare study sites for Sponsor audits and regulatory inspections• Assist in database reconciliation in preparation for study closure• EDC: InForm February, 2017-Present: • All aspects of monitoring for Phase 2 Recurrent Glioblastoma study and Phase 2 study in lung cancer with brain or leptomeningeal metastasis. • Work directly with Sponsor to review and approve subject eligibility• IMV training of in-house CRAs.• EDC: InForm October, 2016-October, 2017: • CRA for phase 2 solid tumor metastatic cancer trial combining monoclonal antibody with TKI in the following select tumor types: endometrial, urothelial, head and neck, renal cell and melanoma.• EDC: InForm2014-2017: • Primary CRA for Phase 1b and Phase 2/3 pancreatic cancer trials • Work closely with Clinical Trial and Data Managers to produce protocol amendments, develop database, interact with vendors, train CRO personnel and perform CRC training at Investigator Meetings • Provide on-site training to members of pharmaceutical company to enhance awareness of site staff and CRA activities during IMVs• Nationwide monitoring of all participating study sites• Perform PSSV, SIV, IMV and closeout visits2012-2014:• All aspects of monitoring for two multicenter, Phase 2 breast cancer trials• All aspects of monitoring for Phase 1 dose escalation oncology study • All aspects of monitoring for multi-center, pivotal device study• Performed interim monitoring visits for Cystic Fibrosis study

• Performed all aspects of monitoring for Phase 3 urology and birth control studies• Performed QA audits for closed and ongoing trials• Conducted interim and close out monitoring visits• Produced comprehensive visit reports and status reports

• Identification of potential investigational sites• Coordinate and perform comprehensive site management for Phase 1-IV clinical trials• Conduct pre−study, initiation, interim and close out monitoring visits• Communicated with sponsors, sites, and colleagues to ensure effective project management.• Performed PK monitoring• Audited study sites on behalf of sponsor company• Performed mentoring/co−monitoring to junior CRAsProjects/Indications: Phase I/II treatment of solid tumors, Phase II treatment of metastatic lung cancer, phase II/III prevention of staphylococcal sepsis in very low birth weight infants, Phase III immunosuppressive medication for kidney transplant subjects, Phase II prevention of Graft versus Host Disease following stem cell transplant; Phase III treatment of nocturia, Phase 1 Bioavailability and Bioequivalence PK monitoring, Phase II treatment of non-Hodgkin’s lymphoma, Phase II treatment of breast cancer, Phase III treatment for chronic pain, Phase II/III treatment of rheumatoid arthritis, Phase 1 PK monitoring, Phase lll treatment of bacterial skin infections, Phase ll treatment of stress urinary incontinence.

• Provided primary gynecologic care to female patients• Diagnosed and treated menstrual, breast, and genito-urinary tract disorders• Provided contraceptive counseling and management• Diagnosed and treated sexually transmitted diseases

• Primary CRA for a multi−center, international cardiovascular study• Tracked timelines and study progress, coordinated monitoring activities for CRAs, reviewed trip reports and correspondence• Conducted pretrial visits and assisted with site and investigator selection; performed all aspects of site monitoring, from qualification visits through termination visits• Mentored new CRAs, participated in CRF and protocol development, and managed 11 sites involved in three different protocolsTherapeutic Areas: Cardiovascular, Immunology/Infectious Diseases, Oncology, Neurology, OB/GYN and Transplantation

• Provided care to antepartum, intrapartum, and postpartum patients as well as to newborn infants• Oriented new personnel and in−serviced medical staff